Strategic aspects of higher education reform to cultivate specialists in diagnostic and biopharma industry as applicable to Predictive, Preventive and Personalized Medicine as the Medicine of the Future by unknown
Studneva et al. The EPMA Journal  (2015) 6:18 
DOI 10.1186/s13167-015-0040-4REVIEW Open AccessStrategic aspects of higher education
reform to cultivate specialists in diagnostic
and biopharma industry as applicable to
Predictive, Preventive and Personalized
Medicine as the Medicine of the Future
М. Studneva2, M. Mandrik2*, Sh. Song7, E. Tretyak8, I. Krasnyuk2, Y. Yamada9, A. Tukavin10, A. Ansari11, I. Kozlov14,
C. Reading12, Y. Ma13, K. Krapfenbauer3, A. Svistunov2 and S. Suchkov1,2,3,4,5,6Abstract
Predictive, Preventive and Personalized Medicine as the Medicine of the Future represents an innovative model
for advanced healthcare and robust platform for relevant industrial branches for diagnostics and pharmaceutics.
However, rapid market penetration of new medicines and technologies demands the implementation of reforms
not only in the spheres of biopharmaceutical industries and healthcare, but also in education. Therefore, the
problem of the fundamental, modern preparation of specialists in bioengineering and affiliated fields is becoming
particularly urgent, and it requires significant revision of training programs of higher education practice into current
medical universities. Modernization and integration of widely accepted medical and teaching standards require
consolidation of both the natural sciences and medical sciences that may become the conceptual basis for a
university medical education. The main goal of this training is not simply to achieve advanced training and
expansion of technological skills, but to provide development of novel multifaceted approaches to build academic
schools for future generations.
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Limitations of the current diagnostic and therapeutic
paradigm
Biopharma as an industrial branch has always been con-
sidered as a strategic industry, being an important com-
ponent of national security that includes the following
typical enterprises and organizations:
 Chemical and pharmaceutical departments and
research chemical and pharmaceutical institutes
 Supervising institutions and organizations for
specific categories of medicinal products* Correspondence: marubinimark@gmail.com
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(http://creativecommons.org/publicdomain/ze Departmental organizations (particularly of the
Ministry of Defense) and so on
 Biopharmaceutical industries including production
of active ingredients
Hence, a complete manufacturing chain has been
available—from the selection of active biological mole-
cules and potential pharmacotherapeutic targets to the
production of the final product and marketing thereof.
This requires corresponding personnel support and a
professional preparation system, including higher edu-
cational institutions, specialized secondary schools, and
post-graduate education (post-graduate qualification, doc-
toral degree, career development system) [1].
Development of medicinal products and preparations
and diagnostic instruments of each next generation is aicle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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of complex biosystems theory and translational medicine
has led to the rampant development of systems biology,
resulting in the active introduction of principally new
approaches into the practice of specialists in pharma-
ceutical design: these are now oriented to the creation of
market products with exclusively high-tech level.
The area of use of such products has been greatly ex-
panded covering the segments of therapeutic-diagnostic
(theranostic), predictive-prognostic, preventive-prophy-
lactic, and rehabilitation instrumentation. This, in turn,
has been dictated by the birth of technological platforms
of principally new generations, on the one hand, and in-
ternal restructuring of the healthcare model replacing the
corresponding segments with groundbreaking innovation
technologies of Predictive, Preventive and Personalized
Medicine (PPPM), on the other hand. And that is why
today the existing market situation strongly requires not
only the update of the biopharmaceutics engineering ideol-
ogy and its technological inventory, but also the acceptance
of more radical steps in terms of rotation of the personnel
and renovation of the whole system infrastructure. Why
so? The latter, having been capable of ensuring the bio-
engineering sectors of the pharmaceutical industry as an
economy segment with personnel, is nowadays progres-
sively and, more importantly, hopelessly and irreversiblyFig. 1 Multitargeting focused on realization of a therapeutic potential of th
modeling. A three-dimensional structure of the target explains a molecular m
docking or computer modeling of the ligand-protein interaction. The docking
of technology development, it is usually conformationally fixed) and the ligan
with the receptor are modeled in the process of docking. The docking makes
procedure analogous to high-performance screening with the use of compu
main advantage of which being that for real pharmacological tests, and it is n
compounds, but only “virtual prototypes.” When the target is selected, the lib
this stage is to detect the compounds that after further modification and test
people. b A pharmaceutical analogous to the ligand is bonded with a protein r
takes place. c A pharmaceutical simultaneously cooperates with several regulato
the protein regulators transmit information to the structural genes used to reguaging, therefore requiring a radical reform from the pool of
bioengineers [2].
The shortage of skilled personnel capable of solving
principally new tasks is felt today even in the majority of
developed countries including the regions with powerful
biotechnological and biopharmaceutical clusters (USA,
Scandinavia, Hong Kong, and others). And this happens
in spite of the fact that over 50 % of the graduates of
pharmaceutical departments of European universities are
oriented to work in the specialized sectors of industries
and affiliated structures thereof.
Thus, with due account of increase in the labor
market of biopharmaceutics and biopharmaceutical
industries, the demand for qualified research and pro-
duction personnel is essentially increasing. At the
same time, the demand for sales managers and mar-
keting specialists is evidently decreasing. The com-
panies oriented for high-technology developments in
creative segments, including (а) multitarget pharmaco-
logical structures oriented for the components being
part of various signal paths (Fig. 1), (b) “companion”
diagnostics (Fig. 2), (c) next-generation sequencing
(NGS) (Fig. 3), or (d) screening for presence of circu-
lating tumor cells (CTCs) in the blood (Fig. 4), and
others are in need of creativity personnel to staff their
search and R&D subdivisions.e drug designed. a Use of high-performance screening and molecular
echanism of interaction of a ligand with protein; it is used for molecular
uses the three-dimensional structure as startup information (at this stage
d structure whose conformational flexibility and mutual arrangement
it possible to reduce the expenses and time due to conducting a
ter environment. This procedure is called virtual screening with the
ot necessary to acquire a complete library consisting of millions of
rary of compounds may be used as a startup set of ligands. The task at
ing may offer a candidate compound for further testing on animals and
egulator but does not activate it. Complete inactivation of a pharmaceutical
rs, as a result of which its partial inactivation is observed. In the process,
late protein synthesis
Fig. 2 The role and place of the “companion” diagnostics as a special segment of the biopharmaceutical market. The diagram shows the ratio of
the number of patients who have obtained a positive result upon receiving a pharmaceutical to the number of patients whose quality of life has
drastically improved after termination of their therapy [20]
Fig. 3 a Methods of next-generation sequencing (NGS). NGS relates to the determination of the initial sequence of DNA or RNA with
further description of the primary sequencing item structure. This technology allows simultaneous reading of several genome sections
which is the main difference as compared with the existing methods of sequencing. NGS is performed with the help of multiple chain
extension cycles induced by polymerase or multiple oligonucleotide ligation. b The ratio of the number of new-generation laboratories
dealing with of genomics. Note that 44 % of the laboratories belong to the higher education structures (in the education category),
38 % belong to the structure of biopharmaceutical enterprises, and 8 % of the laboratories belong to the government
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Fig. 4 a, b Volumes of sales of CTC-products in the world market
and prognosis for 2012–2018 in USD million. а The primary tumor
cells are capable of breaking off from the main tumor mass and
circulate with the blood flow in the organism; such cells are called
circulating tumor cells (CTCs). A solution of diagnostic and predictive
problems is provided by a special technology and device (CellSearch™)
capable of detecting СТСs in the course of blood analysis. The principle
of action of the device is based on the method of immunomagnetic
separation of fractions, followed by fluorescent identification of CTCs.
b Prognosis of СТС technology sales for the period of 2012–2018
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principle, namely, specialists in the field of personalized
genomics, proteomics, drug design, and bioinformatics.
Exactly these specialists are capable not only of engineer-
ing pharmacological structures and predictive-diagnostic
instrumentation of new generations, but also of prognosti-
cating selection of potential pharmacotherapeutic target
candidates out of new (including earlier unknown) families
by determining the production platforms and methods of
quality assurance with them in the corresponding configu-
rations of operation therewith [3].The main terminology used in the pharmaceutical
design consists of pharmacotherapeutic target (PTT) and
target pharmacological structure (TPS) (drug).
PTT is a macromolecular biological structure sup-
posedly associated with a definite function, the violation
of which may cause formation of pathological shifts at
the preclinical stage followed by clinical manifestation of
a disease, which requires a specific action to prevent.
The most frequent targets are receptors and enzymes
(Fig. 5).
TPS is a chemical compound (or biological product)
specifically interacting with the target and capable of
modifying the final cell response (Fig. 6).
Therefore, one of the important aspects of pharma-
ceutical design is selection of the proper PTT through
which it is possible to specifically regulate some biochem-
ical processes or complete metabolic scenarios without
affecting other pathways, if possible. A considerable role
in the process of development of PTT and pharmaceuti-
cals as a whole is played by bioinformatics—integration of
methods of applied mathematics and statistics enabling
not only analysis of the available genomic, proteomic,
and interactive data, but also prediction of the inter-
action of new level interactions on the basis of detected
regularities (Fig. 7).
Quite recently, there has been formed a demand for
new professions: Government relations managers (GR
managers) and experts in validation and pharmacovigi-
lance (Figs. 8 and 9), etc.
For instance, a GR manager is a specialist responsible
for building productive and successful liaisons between a
biopharmaceutical company and government organiza-
tions. By building up trustworthy informal relations with
representatives of public organizations, GR managers
promote prosperity of their enterprises and their sustain-
able development. A GR manager is responsible for the
organization of cooperation, promotion, and protection
of the interests of his/her company in the state executive
bodies and public organizations. The main tasks of GR
managers are to organize meetings and negotiations with
representatives of state establishments, to participate in
specialized exhibition shows and conferences, and to
conduct seminars and presentations for representatives
of state bodies. It is also the competence of the govern-
ment relations manager to organize a political analysis
and keep track of the legislature and political trends and
relevant changes [4].
When developing and introducing new medicines and
technologies into the pharmaceutical market, it is required,
at each stage of a product creation, to evaluate the quality
of semi-finished or finished products. In this context, a
specialty of expert in validation and pharmacovigilance
becomes highly demanded. The duties of such a specialist
are to control the quality of the products manufactured
Fig. 5 Families of potential pharmacotherapeutic targets in the human body. Kinases are enzymes acting as catalysts for the transfer of the
phosphate group from the adenosine triphosphate (ATP) molecule to various substrates. Receptor tyrosine kinases (ТK) act as a catalyst for the
transfer of the phosphate residue from ATP to tyrosine residue of specific cell protein targets. Non-receptor tyrosine kinases are located in the cell
cytoplasm and are attached to cytoplasmic membrane on the inner side. An example may be the SRC protein which has one changed amino
acid in it, inducing hyper-expression of genes and growth of the cell. An ion channel receptor is a pore-forming protein supporting the difference
of potential that exists between the outer and inner sides of the cell membrane in live cells. The GPCR receptor is a G protein-coupled receptor
(relates to the family of transmembrane proteins). Zinc proteases: zinc is a coenzyme of over 60 enzymes in human body. Nuclear receptors
represent DNA-coupling transcriptional factors with conservative domain organization, the activity of which is controlled by lipophilic ligands,
phosphorylation, and interaction with other proteins. Serine proteases are proteases used to modify other proteins by phosphorylation of serine
residue. Phosphatases are enzymes used to dephosphorylate the substrate as a result of ester decomposition of phosphoric acid
Studneva et al. The EPMA Journal  (2015) 6:18 Page 5 of 14including the documentary proof that the process of
manufacture of the end product meets the corresponding
requirements and brings the expected results, to inform
medical institutions about undesirable adverse reactions of
pharmaceuticals, and so on.Fig. 6 Interaction pattern in a polymer-pharmaceutical-ligand
conjugation
Fig. 7 Components of bioinformatics. Genomics is a branch of
science studying structural and functional organization of a genome.
Proteomics is a branch of science focusing on proteins and their
functions and interactions in living organisms. Metabolomics is a
branch of science studying the particulars of metabolic pathways.
Bioinformatics develops algorithms for the prognostication of the
spatial structures of proteins and other biomolecules as well as
evaluates the character of control of complex biological systems.
Thanks to these informational technologies, it has become possible
to model pharmaceuticals, drastically reducing the time for creation
of pharmacological structures of principally new generations
Fig. 8 Traditional process of selecting human resources by qualification
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possible without preparation of specialists on a wide
interdisciplinary basis including the following specialties:
(a)Chemists, biologists, and bioinformatics specialists
focused on applied bioengineering and developing
not only drugs, but also the ideology of their
creation on the basis of mathematical modeling
and selection of PTT in the course of designing of
therapeutic-diagnostic instruments of the future
(b)Pharmacologists and clinicians responsible for
the conduct of preclinical and clinical research
(c)Technologists of a biopharmaceutical plant equipped
with process lines and platforms of new generations
(d)Specialists in the field of certification, validation, and
licensing of the end product [5]Fig. 9 The process of qualification selection. Activities of the FDA on superCorrespondingly, implementation of reforms in prac-
tical healthcare and naturally in the spheres of bio-
pharmaceutical industries as their integral component
requires effective measures in the policy of human re-
sources (HR), which may allow to qualitatively change
the HR potential in the biopharmaceutical industries, to
adapt it to new conditions, and to execute the tasks fore-
seen in the reforms.
The concepts discussed above all point to the insight that
for successful commercialization of a biopharmaceutical
product, it is important that the specialists ensuring each
stage of its development have a clear picture of the
complete “path” (a translation procedure) of the medical
product—from the search for a biologically active substance
or creation of its virtual biostructure to the marketing of
the finished product. Therefore, educational programs ofvising the market release of validated pharmaceuticals
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higher education should be directed to satisfy the needs of
the biopharmaceutical sector in the aforementioned spe-
cialists—a subject of great interest to the professional
society.
The role of bioengineering and biopharmaceutical
industries in modern society
The achievements of modern bioengineering and bio-
technology have a qualitative effect on many spheres of
human activities and play an ever greater role in solving
key problems of human life. Naturally, these achieve-
ments ensure controlled obtainment of useful products
for various spheres of human life and are based on
utilizing the functional potential of separate biomole-
cules, cells, whole cell systems, and living systems of
various degrees of complexity.
However, a real breakthrough in the sphere of pharma-
ceutical design has been provided by completion of the
“Human Genome Project,” leading to a totally new ap-
proach to the search and selection of potential pharma-
cotherapeutic targets of new generations, accessible to
analytics directly in the genome text. The instrument for
the analysis of such type of data massif will be bioinfor-
matics, which has already led to a revolution indeed in
biotechnology [6–8].
Clearly, progress and leadership of the USA in bio-
technology and affiliated fields may be explained not
only by huge investments into biopharmaceutical indus-
tries, but also by special attention to the role of profes-
sional specialists of new generations. Preparation of such
specialists is one of the most important elements of the
United States educational policy, the basis of which
among other things is the phenomenon of intensive
cooperation of university science with private pharmaco-
logical business.
Strong attention to the development of biotechnology is
paid in the countries of the European Union, where the
total biotechnological market has crossed the mark of 120
billion euro. Positions are also strong in South Korea,
China, Japan, Great Britain, Germany, and Scandinavia.
It is precisely for this reason that the problem of prep-
aration of specialists in bioengineering and affiliated
fields is becoming particularly urgent.
The objective necessity of educational reform in the
sphere of bioengineering and biopharmaceutical
industries: problems and solutions
In the world of accelerated scientific and technical pro-
gress that we are now witnessing, the today’s obsolete
education model does not give fundamental knowledge.
As discussed above, the increase in quality of training pro-
grams in universities is a priority of modern educational
policy; this increase shall be based, in terms of qualityassurance issues, on the role of the government in regulat-
ing, financing, and monitoring through the procedures of
accreditation, licensing, and attestation [9].
Higher quality of the system of preparation of new-
generation professionals implies not only the quality of
the functioning system final results, but also as the qual-
ity of the process itself, which should start as early as
from a pre-higher education training of future bioengi-
neers. Special significance here should be paid to the
viability of the system to select talented young specialists
and promptly involve them into creative activities [10].
Then follows university education, the effectiveness of
which may be evaluated with the help of the following
complex criteria: the content quality of the main and
post-higher educational institution educational programs
and the quality of the process of realization of educa-
tional programs. At this stage, most important becomes
the integration of science, education, and real production
which helps integrate the resources of universities, the
Russian Academy of Sciences, and business structures by
way of creating various integrated structures (for instance,
technology incubators, education-production centers, and
others) and thus considerably increasing the effectiveness
of preparation of personnel. This in turn requires the devel-
opment and employment of problem-oriented technologies
of biopharmaceutical education within the framework of
continuous programs of specialist preparation. It becomes
quite evident that higher, secondary-level and first-level edu-
cation should be integrated into a single chain having the
main task—to create a bioengineer of the future [11, 12].
Issues of preparation of personnel for bioengineering and
pharmaceutical design, and ways of solution
At present, one of the main problems of preparation of
biotechnologists and bioengineers is the absence of mod-
ern and well-equipped bases for the production practice
and, correspondingly, absence of a possibility for practical
training and forming of adequate sets of professional skills
with the trainees (future specialists) [13].
One of the solutions for this issue has become the
introduction of federal state standards of secondary-level
vocational education of the new generation. The main
difference of the federal state standards of this third
generation from the previous educational standards is a
modular-competence carrying approach.
Competences is an algorithm of specialist actions which
manifest themselves in practical activities and social inter-
actions. It is exactly the module as a new structural elem-
ent that holds the central place in the content of vocational
education, since the requirements to the results of training
are formed as a list of the types of professional activities
and corresponding professional competences. A graduate
of the training course should, first of all, acquire practical
experience based on the complex of skills and knowledge
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ently, and their integrity permits to reach final competence
in a particular professional sphere.
Complex, synchronized study of theoretical and prac-
tical aspects of each type of professional activities is per-
formed within the framework of such modules. With
regard to the abovementioned, the excessive theoretical
disciplines are not so much reduced as their content is
revised. That is, one envisions a kind of “sifting” of ex-
cess theory and reshuffling of the volume to emphasize
the most necessary theoretical knowledge to enable mas-
tery of the competences by arranging them in an orderly
fashion and systematizing them, which, in the long run,
increases the motivation of the trainees [14].
The central moment in the work to introduce the
competence approach modular technology into the edu-
cational process is such forms of organization of educa-
tional activities that are based on self-dependence and
responsibility for the results of work on the part of
trainees themselves. The organized training process
enables the student to develop self-dependence during
lectures, seminars, laboratory classes, and extracurricular
works, and allows independent execution of individual
tasks which greatly expands one’s knowledge, develops
skills, and helps develop a creative approach and ability
to find one’s place in the growing flow of scientific
information.
One more important problem is the quality of educa-
tion being received. To solve this problem, it is proposed
to introduce into practice new pedagogical technologies
directed at full and conscientious understanding of the
material under study. One of such models is the model
of interactive training of students (Fig. 10, diagrams 1
and 2) [15].
As distinguished from active methods, the interactive
methods are oriented for wider interaction of students
not only with the instructor, but also with one another
and for the dominancy of activity of students in the
process of training. Interactive material presentation
should be planned beforehand, since such training re-
quires constant control over the trainees. When the
instructor addresses the students with questions or tries
to involve them into discussion, he/she should always
know in which direction the discussion may go andFig. 10 Forms of interaction of students with lecturercontrol the course of discussion. The task of the in-
structor is to help the group to point out a definite problem
and direct the course of discussion towards clarification
and solving the problem set. By using answers and consid-
erations proposed by the students, the instructor encour-
ages the students to work over the material and boosts up
their interest in the issue under discussion in order to ac-
centuate the correct provision. The “directed discussion”
requires skill and ability on the part of the instructor to
clearly set up the direction of the discussion by smoothly
changing the course of discussion as well as re-phrasing the
answer by giving it the right tint and stressing the right
accents.
The directed discussion may be dedicated to the whole
lesson, or a small series of questions-answers may be
built into the speech of the instructor. An effective
method to attract attention of students to important
information is listing of questions at the beginning of
the lecture. Besides, it is necessary to show that the in-
structor has noted the efforts made by the student. The
main objective of the directed discussion is activation of
brainwork of students and their involvement in the
training process. Important difference of interactive
exercises and tasks from ordinary ones is that when
performing interactive exercises, students not only and
not so much as make fast the already studied material,
as study new material.
The interactive training expects the logics of the train-
ing process to differ from the ordinary process: not from
theory to practice, but from shaping new experience to
its theoretical understanding through the use of the lat-
ter. Experience and knowledge of educational process
participants serve as a source of their mutual training
and mutual enrichment. By sharing their knowledge and
experience, the participants take upon themselves a
portion of the instructor’s educational functions, thus in-
creasing their motivation and training productivity.
An effective interactive method, very important for
formation of skills for work, is demonstration. The fea-
ture of this method is the possibility to illustrate the sub-
ject under discussion for its better adoption. Thus, by
using interactive methods, we set ourselves a task not
only to give the students general knowledge, but also to
form a definite level of expertise and skills so that in fu-
ture work, particularly when using biological agents (mi-
croorganisms, plant and animal cells, and parts thereof:
cell membranes, ribosomes, mitochondria, chloroplasts),
future specialists in biotechnology and pharmaceutical
design may feel at ease and demonstrate maturity and
common sense when trying to obtain valuable products
and carrying out target transformations [16].
Integration of science and education is important to in-
crease the quality of preparation of specialists. For example,
within the framework of higher educational institution
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departments and research institutes with similar interests
to create scientific and educational complexes having a
common academic council and administration system. By
doing this, university lecturers do scientific work in re-
search institutes, researchers give lessons in university
departments, and the academic council coordinates all this
complex work and approves educational plans of depart-
ments and research plans in research institutes.
A number of universities have already organized educa-
tion-science-innovation complexes (ESIC) for the purpose
of increasing the quality of education and strengthening
the liaison with the production. The specifics of ESIC con-
sists in that, thanks to the cooperation of scientific
research and educational and production capacities, there
is ensured a new quality of education, development of
research, and commercialization of the results of scientific
and technological joint performance.
Creation of ESIC on the basis of a structural sub-
division of a higher educational institution/university (a
department, laboratory of a research institute, pilot-scale
production of university) without establishment or attrac-
tion of a legal entity permits to avoid problems associated
with the interaction of two and more legal entities, espe-
cially when they have different forms of incorporation. In
this case, it becomes easier to solve questions associated
with intellectual property and organize joint educational,
scientific, and innovation processes. Setting up of ESIC on
the basis of a university and a large industrial enterprise
permits developing long-term cooperation and prepar-
ation of duly trained personnel for the needs of the bio-
pharmaceutical industry.
A problem of great concern is how to prepare gradu-
ates of secondary-level schools to education in universi-
ties—our potential students. Today, we are forced to
admit the discrepancy between the skills of a secondary-
level school graduate and the skills necessary for the fast
and successful adaptation of a student to study in a univer-
sity. To overcome this, we need to think about organizing
a close contact in the “secondary school-university” link. In
this regard, a sufficiently attractive idea is to “incorporate”
the last stage of secondary-level education into the struc-
ture of higher education. We need to revive old traditions
and offer universities the resources and possibilities to
organize a pre-university training in our physico-technical,
physico-mathematical, and ecological-biological system and
other schools operating on the basis of universities. This
will help to attract academic staff to teach at such schools,
make use of higher school teaching technologies, and re-
duce the time for adaptation of students.
In addition to the creation of a “secondary school-uni-
versity” cluster with the aim to increase the quality of
education, a particular place in preparation of bioengi-
neers is occupied by the “secondary school-university/college-production” cluster. The cluster pattern of this
system will help prepare a competent employee for the re-
gional labor market and achieve maximum result in a
minimum time limit. Exactly, the cluster approach prede-
termines a mutually beneficial relationship, uninterrupted-
ness, and cooperation. It is evident that active joint
functioning of educational establishments with pro-
duction facilities will create favorable conditions for
increasing their investment attractiveness and competi-
tiveness of graduates at the regional labor markets [17].
The demonstrated “good practices” uniting educational
and innovation activities in universities show that with the
established ties with revived or newly organized private en-
terprises, the scientific and educational cooperation starts
its active growth. In short, the state, market and produc-
tion, universities, and research institutes should promote
expansion of the biopharmaceutical sector of economics,
contribute to effective national industrial policy, and sti-
mulate innovations of small businesses, thus facilitating
the progress of society as a whole.
PPPM as an innovation model of advanced healthcare
and sector of biopharmaceutical industry and
pharmaceutical design
The purpose of employment of the knowledge, skills, and
resources of biopharmaceutical science and biopharma-
ceutical industry is to predict and prevent diseases, in-
crease the life expectancy, and strengthen and preserve
human health through organized efforts of society.
The essence of the new model of advanced health-
care—PPPM—is in guiding the human body reserves,
and its main purpose is not healing the diseases, but
detecting concealed anomalies in organisms and taking
targeted measures directed at the liquidation of such
anomalies and preventing diseases. Naturally, such type of
global change could be obtained only with active introduc-
tion of fundamental science achievements into life,
making it possible to get inside the affected biostructures
with conditions to visualize the damaged sites (including
those concealed from the doctor’s eyes) with further
liquidation thereof at the preclinical stage and thus pre-
venting the beginning of disease.
Today, we already observe growth in the share of pre-
dictive and preventive medications in the overall spectrum
of developed and manufactured drugs. This requires or-
ganizing, in the medical and chemico-pharmaceutical
higher educational institutions, special educational pro-
grams incorporating technological and other aspects of
modern biopharmaceutics including the tasks of PPPM-
affiliated branches of the biopharmaceutical industry [18].
In this regard, the reform of pedagogical process and cre-
ation in the structure of medical universities of relevant
chairs and later PPPM departments will reflect the system-
atic approach to form innovation infrastructures with the
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pharma industry. The requirements to the specialists of the
future, i.e., specialists in the field of pharmaceutical design,
traditional medicine, and bioinformatics, will also change.
Correspondingly, at this stage, the training programs
should include the tasks of training the students and
planting skills in the following fields:
 Understanding of the key molecular mechanisms
of disease development and designing models of
pathophysiologic mechanisms of the latter with
preliminary selection of potential pPTT
 Identification of basic structural-functional shifts in
the physiological architectonics of cell biomolecules
causing generation of cell pathology, pathology of
intercellular interactions, and, as a result, the overall
pattern of clinical symptomatics
 Screening of biomarkers necessary for use in
predictive diagnostics, prognostication, and
monitoring of diseases at the preclinical and
clinical stages of disease
 Understanding of the principles of modern
diagnostics, and analysis and interpretation of
laboratory data permitting to perform identification of
key cellular shifts when various pathologies are formed
 Use of molecular targets with the aim of
prophylactics and prevention of disease at the
clinical stage or typical pathological process at the
preclinical stage
A graduate of specialized courses should naturally
know the following:
 Theoretical and methodological basis of
fundamental medicine corresponding to the
contemporary level of world knowledge in the field
of systems biology and fundamental biomedicine
 Principles of designing of a model of pathological
process with identification of biomarkers and
selection of targets necessary for effective control
of pathological process
 Pool of modern technologies used to improve the
effectiveness of the analytical cascade including
the use of interdisciplinary approaches and
modernization of the integrated infrastructure of
the biopharma industry
The PPPM specialists should be experts not only in
interdisciplinary (legal, organizational, and statistical) fields
of action, but also in the fundamental spheres that offer, on
the one hand, a clue to the principally new pharmaceuticals
and diagnostic technologies, and, on the other hand,
personalization of diagnostic reports, prevention, and
prophylactics. Such researchers-experts should possesstechnologies of planning and standardization, and their
preparation requires restructuring of programs for pre-
university (school), university, post-graduate, and basic
medical education with the formation of principally
new interdisciplinary programs which will be oriented
for training and retraining of specialists in the PPPM-
affiliated directions.
Correspondingly, preparation of specialists capable of
building the interdisciplinary healthcare system of the
future should be built on the novel principles taking into
account the following:
 Common architectonics of pre-university, university,
and post-graduate education
 Features of introducing a secondary school-university
pair into international educational environment
 The role of additional or further education and
bioinformational technologies as the basis of such
environment
 Principles of design in the structure of additional
education and design of business, research, and
engineering
 A rigid necessity of a multiple-level testing and dialog
in the learner-teacher pair with due account of person-
ality characteristics of the two when forming vocational
self-sufficiency and professional potential of a specialist
as a personality of the future
 The value of innovation risks of the educational
process and possibility to monitor such risks in case
of emergency situations
This educational model should contain the following:
 Educational-methodological kernel
 Key platforms of basic knowledge and qualities
 A system of group and individual vectors
demonstrating priority directions and substantive
potentials of intensiveness and quality of knowledge
development
Thus, for instance, the first (pre-university) level of
education familiarizes school children with the modern
model of PPPM (without deep study of any separate
aspects).
The second (university) level implies deep studying of
fundamental (theoretical) and applied (translational) as-
pects of PPPM among the students.
The core of the third (post-graduation) level is dedi-
cated to interdisciplinary aspects of PPPM affiliated to
resident doctors and post-graduate students.
In this respect, the starting point of training in the field
of high technologies of school children is of particular
importance (mainly senior school children), this training
being organized on the basis of leading academic and
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specialist and upbringing his/her creative personality
should not only be solved at the stage of post-university
adaptation in real work, but also start at the stage of train-
ing sessions in the pre-university (at school) phase with
simultaneous conduction of specialized workshops. And,
since the school program is of great importance to the fu-
ture education and vocational careers of our specialists, it
is necessary to unite efforts of teachers, administrators of
universities, and political leaders for the development of
educational programs on modern biopharmaceuticals in
the secondary-level schools and colleges [19].
A team of young scientists—our hope in the
development of domestic biopharma industry
Taking into consideration the current trends and personal
experience, we have made first steps for closer liaison of
the secondary school-university pair and restructuring of
specialized (medical-biological) classes to turn school chil-
dren towards direct participation in the modernization of
the biopharmaceutical industry system. Guided by the
abovementioned facts, a quite non-standard approach has
been the organization of a young scientist team which has
acquired an official status with the international research
group in the European Association for Predictive, Prevent-
ive, and Personalised Medicine (EPMA). The characteristic
feature of this group was that in addition to the resident
doctors and students of Moscow universities, the group
comprised the first school children of Education CenterFig. 11 Creators-founders of the international young scientists teamNo. 204 named after А.M. Gorky (a Federal State-Funded
Educational Institution) and students of non-medical
universities having interest in allied profession (Figs. 11,
12, and 13).
Used as an educational-methodical kernel is a three-
level basic education system (pre-university, university,
and post-university education). The genome and post-
genome technologies have occupied a special place
among the basic platforms as well as methods of cellular
and tissue-specific bioengineering. Group and individual
vectors as part of the basic inventory are represented by
the branch segments including pharmaceutical design,
translational medicine, bioinformatics, and others—i.e.,
vectors incorporating all modern technological platforms.
Attention should be paid to a number of essential mo-
ments which appeared as a result of the first experiments.
First, not only students of universities, but also individual
school children have started their research work by select-
ing leading academic research institutes, and as the subject
of research, they have chosen most recent technologies re-
lating to genome and post-genome topics requiring from
the specialists-bioengineers many a year of continuous
training for forming corresponding competences.
Second, one of the most pressing and controversial prob-
lems in the system of innovation specialist preparation is
the problem of adaptation of university graduates in the
real production environment, i.e., at innovation biopharma-
ceutical enterprises connected with research centers that
generate innovation products. Here, for senior school age,
Fig. 12 Members of the international young scientists team at the First International Congress on PPPM, Bonn, Germany, 2011
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tivity as a means of his/her professional self-determination;
hereby, the “object of design” is the schoolchild who de-
signs (“forms”) his/her abilities necessary to master the
chosen profession. Actually, as for schoolchildren, this is
the research work which gives rise to love of sciences and
the creative profession of a bioengineer.Fig. 13 Members of international young scientists team at the Second Inte
results, Brussels, European Parliament, 2013In work with gifted children, the innovation technolo-
gies occupy a special place, since the purpose of such
work is the development of intellectual and creative po-
tential of the child personality by developing the research
abilities of the latter. The results of mutual work and with
gifted children and the relevant educational process has
been taken by us as the basis for the evaluation of thernational Congress on PPPM during discussion of training program
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or the post-graduate student-student-schoolchild triplet.Conclusions
Our model for accelerated development of continuous
vocational education in the sphere of biopharmaceutics
and biopharmaceutical industries is based on the com-
binatorial approaches (competence, module, personality-
activity, program-design, and problem-oriented) to the
elucidation of innovative processes of modernization
of the existing system. Correspondingly, the unit to
build up the content of educational programs and sites
is the task of pedagogics oriented for the innovation
context in education development, and it allows each
hearer to organically combine individual and group
work with the aim to enrich oneself with the experi-
ence of the colleagues and also to use own professional
experience.
The use of the accelerated model for development of
continuous vocational education has required a new type
of organization of the educational process. The place of
formalized methods and means of education focused on
the transfer and learning of information is now occupied
by innovation and interactive, problem- and practice-
oriented, and research-and-design methods. All that en-
sures solving of pedagogical problems on the basis of con-
structive dialog, exchange of opinions, role and positional
interaction, practical solution of educational tasks, and use
of information technologies.
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